endocrine issues associated with dm1 and dm2
Published 9 years ago • 1.1K plays • Length 1:18:56Download video MP4
Download video MP3
Similar videos
-
48:04
how common is myotonic dystrophy in the united states? findings from the recent prevalence study
-
56:30
what's happening with dm2 research?
-
23:56
insights into muscle pathology: imaging analysis & clinical endpoints in myotonic dystrophy type 2
-
1:15:42
dm1: disease development, symptoms, & management - 2021 mdf annual conference
-
1:05:52
understanding dm2 - 2022 mdf annual conference
-
55:00
dm2 research update
-
1:17:22
dm2: disease development, symptoms, & management - 2021 mdf annual conference
-
1:00:15
understanding the foundations of dm research
-
54:33
dyne therapeutics - meet the dm drug developers
-
55:09
dyne therapeutics - meet the dm drug developers
-
58:49
treatment options for pain
-
50:54
nutritional issues related to dm
-
4:44
myotonic dystrophy, causes, signs and symptoms, diagnosis and treatment.
-
1:11:57
multi-systemic and cognitive aspects of myotonic dystrophy type 2
-
1:31
pain and dm2
-
5:07
living with dm: the community speaks
-
53:07
dyne therapeutics demonstrating force™ platform delivery to cns - 2023 meet the dm drug developers
-
53:31
most commonly asked questions about dm
-
58:35
future directions of dm research (part 2) - 2022 mdf annual conference